Clinical trial

Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial…

NCT00433966 · Cardiovascular Research Foundation, New York, Other · Completed

Key facts

NCT number NCT00433966
Title Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
Official title Dual Arm Factorial Randomized Trial in Patients w/ST Segment Elevation AMI to Compare the Results of Using Anticoagulation With Either Unfractionated Heparin + Routine GP IIb/IIIa Inhibition or Bivalirudin + Bail-out GP IIb/IIIa Inhibition; and Primary Angioplasty With Stent Implantation With Either…
Lead sponsor Cardiovascular Research Foundation, New York, Other
Collaborators Boston Scientific Corporation Industry The Medicines Company
Status Completed
Phase Phase 3
Study type Interventional
Conditions Myocardial Infarction
Intervention type Device, Drug
Interventions Bivalirudin, Unfractionated heparin, Bare metal stent, Paclitaxel-eluting stent
Enrollment 3,602
Start date Mar 1, 2005
Primary completion Jun 1, 2008
Completion Nov 1, 2010
First posted Feb 12, 2007
Last update posted Dec 4, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies